Literature DB >> 14602923

DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.

Mirko Marabese1, Faina Vikhanskaya, Cristina Rainelli, Toshiyuki Sakai, Massimo Broggini.   

Abstract

p73 is a member of the p53 family often overexpressed in human cancer. Its regulation, particularly following DNA damage, is different from that of p53. Following DNA damage, we found induction of p73 at both the protein and mRNA levels. Furthermore, by using different p73 promoter fragments, we found a role for E2F1 in mediating transcription of p73. However, this observation alone does not account for the observed DNA damage-induced activation of p73 in the cells used in these experiments. By analyzing the p73 promoter sequence, we revealed a new mechanism of p73 induction associated with the removal of transcriptional repression from the p73 promoter. We found, in fact, that treatment of cells with DNA damaging agents induced nuclear export of the transcription factor C-EBPalpha and blockage of this export abolished drug-induced p73 activation. We also show that C-EBPalpha has a direct repressive activity on transfactor E2F1, and for this repression the binding of C-EBPalpha to its consensus sequence in the DNA is required. These data suggest that in normal conditions a repressor complex involving C-EBPalpha, E2F1 and perhaps other proteins is present on the p73 promoter. This repressor complex is destroyed following damage by removal of C-EBPalpha from nuclei.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602923      PMCID: PMC275563          DOI: 10.1093/nar/gkg869

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  48 in total

1.  The potential tumor suppressor p73 differentially regulates cellular p53 target genes.

Authors:  J Zhu; J Jiang; W Zhou; X Chen
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

Review 2.  The p53 network.

Authors:  M L Agarwal; W R Taylor; M V Chernov; O B Chernova; G R Stark
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

3.  Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma.

Authors:  H Takahashi; S Ichimiya; Y Nimura; M Watanabe; M Furusato; S Wakui; R Yatani; S Aizawa; A Nakagawara
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

Review 4.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

5.  Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53.

Authors:  F Vikhanskaya; L Clerico; M Valenti; M S Stanzione; M Broggini; S Parodi; P Russo
Journal:  Int J Cancer       Date:  1997-07-03       Impact factor: 7.396

6.  Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

Authors:  F Bunz; P M Hwang; C Torrance; T Waldman; Y Zhang; L Dillehay; J Williams; C Lengauer; K W Kinzler; B Vogelstein
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

7.  Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

Authors:  M Kaghad; H Bonnet; A Yang; L Creancier; J C Biscan; A Valent; A Minty; P Chalon; J M Lelias; X Dumont; P Ferrara; F McKeon; D Caput
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

8.  Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers.

Authors:  S Nomoto; N Haruki; M Kondo; H Konishi; T Takahashi; T Takahashi; T Takahashi
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

9.  DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

Authors:  S Y Shieh; M Ikeda; Y Taya; C Prives
Journal:  Cell       Date:  1997-10-31       Impact factor: 41.582

10.  Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.

Authors:  F Vikhanskaya; S Vignati; P Beccaglia; C Ottoboni; P Russo; M D'Incalci; M Broggini
Journal:  Exp Cell Res       Date:  1998-05-25       Impact factor: 3.905

View more
  14 in total

1.  p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

Authors:  Marshall Urist; Tomoaki Tanaka; Masha V Poyurovsky; Carol Prives
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

Review 2.  Autophagy and genomic integrity.

Authors:  A T Vessoni; E C Filippi-Chiela; C Fm Menck; G Lenz
Journal:  Cell Death Differ       Date:  2013-08-09       Impact factor: 15.828

Review 3.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

4.  DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells.

Authors:  Jin Hyup Lee; Shobhan Gaddameedhi; Nuri Ozturk; Rui Ye; Aziz Sancar
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

5.  Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis.

Authors:  Jin Hyup Lee; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

6.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

7.  p73α1, a p73 C-terminal isoform, regulates tumor suppression and the inflammatory response via Notch1.

Authors:  Kyra Nicole Laubach; Wensheng Yan; Xiangmudong Kong; Wenqiang Sun; Mingyi Chen; Jin Zhang; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-26       Impact factor: 12.779

8.  TAp73 protein stability is controlled by histone deacetylase 1 via regulation of Hsp90 chaperone function.

Authors:  Jin Zhang; Enshun Xu; Xinbin Chen
Journal:  J Biol Chem       Date:  2013-01-29       Impact factor: 5.157

9.  E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.

Authors:  Abhik Saha; Jie Lu; Lise Morizur; Santosh K Upadhyay; Mahadesh Prasad Aj; Erle S Robertson
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

Review 10.  p73 as a pharmaceutical target for cancer therapy.

Authors:  Andrea Bisso; Licio Collavin; Giannino Del Sal
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.